MedTrace Logo

Contralateral Comparison of Three Excimer Laser Systems in Performing LASIK

NCT00821236 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2013-03-01

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to compare LASIK outcomes using the WaveLight ALLEGRETTO WAVE™ wavefront guided or optimized excimer laser treatment with the AMO/VISX CustomVue™ and the LADARVision 4000 excimer laser treatment.

Standard refractive outcomes such as uncorrected and best corrected visual acuity, and intended vs. achieved postoperative refractions will be evaluated; in addition, high order optical aberrations, contrast sensitivity, and topography will be measured.

Conditions

  • Myopia
  • Astigmatism

Interventions

DEVICE

Excimer Laser

WaveLight ALLEGRETTO WAVE™ wavefront guided or optimized excimer laser treatment

DEVICE

AMO/VISX CustomVue™

Excimer Laser

DEVICE

LADARVision 4000 excimer laser

Excimer Laser

Sponsors & Collaborators

  • Alcon Research

    collaborator INDUSTRY

  • Durrie Vision

    lead OTHER

Principal Investigators

  • Daniel S. Durrie, MD

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-01-31
Primary Completion
2010-02-28
Completion
2010-02-28

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00821236 on ClinicalTrials.gov